Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1970 1
1975 1
1976 1
1979 1
1980 1
1985 1
1990 1
1992 2
1993 1
1994 2
1995 2
1996 1
1997 2
1999 2
2000 3
2001 5
2002 7
2003 6
2004 10
2005 31
2006 31
2007 28
2008 32
2009 31
2010 69
2011 506
2012 661
2013 590
2014 686
2015 611
2016 671
2017 626
2018 491
2019 623
2020 777
2021 510
2022 366
2023 343
2024 137

Text availability

Article attribute

Article type

Publication date

Search Results

6,894 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome.
Cabañas R, Ramírez E, Sendagorta E, Alamar R, Barranco R, Blanca-López N, Doña I, Fernández J, Garcia-Nunez I, García-Samaniego J, Lopez-Rico R, Marín-Serrano E, Mérida C, Moya M, Ortega-Rodríguez NR, Rivas Becerra B, Rojas-Perez-Ezquerra P, Sánchez-González MJ, Vega-Cabrera C, Vila-Albelda C, Bellón T. Cabañas R, et al. J Investig Allergol Clin Immunol. 2020;30(4):229-253. doi: 10.18176/jiaci.0480. Epub 2020 Jan 14. J Investig Allergol Clin Immunol. 2020. PMID: 31932268 Free article. Review.
BACKGROUND AND OBJECTIVE: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a complex multisystemic severe drug hypersensitivity reaction whose diagnosis and management are troublesome. DRESS syndrome requires management by various specialist …
BACKGROUND AND OBJECTIVE: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a complex multisystemic severe …
TRPA1 as a therapeutic target for nociceptive pain.
Souza Monteiro de Araujo D, Nassini R, Geppetti P, De Logu F. Souza Monteiro de Araujo D, et al. Expert Opin Ther Targets. 2020 Oct;24(10):997-1008. doi: 10.1080/14728222.2020.1815191. Epub 2020 Sep 11. Expert Opin Ther Targets. 2020. PMID: 32838583 Free PMC article. Review.
We conducted a literature search in PubMed up to and including July 2020. EXPERT OPINION: Our understanding of the molecular mechanisms underlying the sensitization of central and peripheral nociceptive pathways is limited. ...
We conducted a literature search in PubMed up to and including July 2020. EXPERT OPINION: Our understanding of the molecular m …
CYP2D6 pharmacogenetics and phenoconversion in personalized medicine.
Nahid NA, Johnson JA. Nahid NA, et al. Expert Opin Drug Metab Toxicol. 2022 Nov;18(11):769-785. doi: 10.1080/17425255.2022.2160317. Epub 2023 Jan 3. Expert Opin Drug Metab Toxicol. 2022. PMID: 36597259 Free PMC article. Review.
EXPERT OPINION: Considering the extent and impact of genetic polymorphisms of CYP2D6, phenoconversion by the comedications, and contribution of CYP2D6 in drug metabolism, CYP2D6 pharmacogenetics is essential to ensure drug safety and efficacy. U …
EXPERT OPINION: Considering the extent and impact of genetic polymorphisms of CYP2D6, phenoconversion by the comedications, an …
Triple-negative breast cancer: promising prognostic biomarkers currently in development.
Sukumar J, Gast K, Quiroga D, Lustberg M, Williams N. Sukumar J, et al. Expert Rev Anticancer Ther. 2021 Feb;21(2):135-148. doi: 10.1080/14737140.2021.1840984. Expert Rev Anticancer Ther. 2021. PMID: 33198517 Free PMC article. Review.
Biomarkers reviewed include epidermal growth factor receptor (EGFR), vascular endothelial growth factors (VEGF), fibroblast growth factor receptor (FGFR), human epidermal growth factor receptor 2 (HER2), androgen receptor, NOTCH signaling, oxidative stress/redox signaling, microR …
Biomarkers reviewed include epidermal growth factor receptor (EGFR), vascular endothelial growth factors (VEGF), fibroblast growth factor re …
Targeting AKT for cancer therapy.
Shariati M, Meric-Bernstam F. Shariati M, et al. Expert Opin Investig Drugs. 2019 Nov;28(11):977-988. doi: 10.1080/13543784.2019.1676726. Epub 2019 Oct 12. Expert Opin Investig Drugs. 2019. PMID: 31594388 Free PMC article. Review.
We also explore the efficacy of AKT inhibitors as monotherapies and in combination with cytotoxic and other targeted therapies.Expert opinion: The complex mechanism following AKT inhibition requires the addition of other therapies to prevent resistance and improve c …
We also explore the efficacy of AKT inhibitors as monotherapies and in combination with cytotoxic and other targeted therapies.Expert …
CSF, blood-brain barrier, and brain drug delivery.
Pardridge WM. Pardridge WM. Expert Opin Drug Deliv. 2016 Jul;13(7):963-75. doi: 10.1517/17425247.2016.1171315. Epub 2016 Apr 11. Expert Opin Drug Deliv. 2016. PMID: 27020469 Review.
AREAS COVERED: Drug distribution into the CSF is a function of drug transport across the choroid plexus, which forms the blood-CSF barrier, and not drug transport across the BBB, which is situated at the microvascular endothelium of brain. ...EXPERT …
AREAS COVERED: Drug distribution into the CSF is a function of drug transport across the choroid plexus, which forms the blood …
Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations.
Bodó I, Amine I, Boban A, Bumbea H, Kulagin A, Lukina E, Piekarska A, Zupan IP, Sokol J, Windyga J, Cermak J. Bodó I, et al. Adv Ther. 2023 Jun;40(6):2752-2772. doi: 10.1007/s12325-023-02510-4. Epub 2023 Apr 18. Adv Ther. 2023. PMID: 37072660 Free PMC article.
Given the lack of evidence-based data for some clinical situations encountered in real life, we identified specific populations of patients who may benefit from switching to proximal C3 from terminal C5 inhibition. METHODS: The expert recommendations presented here were cr …
Given the lack of evidence-based data for some clinical situations encountered in real life, we identified specific populations of patients …
An update on the importance of plasma protein binding in drug discovery and development.
Di L. Di L. Expert Opin Drug Discov. 2021 Dec;16(12):1453-1465. doi: 10.1080/17460441.2021.1961741. Epub 2021 Aug 17. Expert Opin Drug Discov. 2021. PMID: 34403271
Introduction: Plasma protein binding (PPB) remains a controversial topic in drug discovery and development. Fraction unbound (f(u)) is a critical parameter that needs to be measured accurately, because it has significant impacts on the predictions of drug-drug …
Introduction: Plasma protein binding (PPB) remains a controversial topic in drug discovery and development. Fraction unbound (f(u)) i …
The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy.
Albadari N, Deng S, Li W. Albadari N, et al. Expert Opin Drug Discov. 2019 Jul;14(7):667-682. doi: 10.1080/17460441.2019.1613370. Epub 2019 May 9. Expert Opin Drug Discov. 2019. PMID: 31070059 Free PMC article. Review.
Moreover, this review summarizes recent insights into the therapeutic approaches targeting the HIF-1/2 pathway. Expert opinion: More studies are needed to unravel the extensive complexity of HIFs regulation and to develop more precise anticancer treatments. ...
Moreover, this review summarizes recent insights into the therapeutic approaches targeting the HIF-1/2 pathway. Expert opinion …
Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study.
Suehs CM, Menzies-Gow A, Price D, Bleecker ER, Canonica GW, Gurnell M, Bourdin A; Oral Corticosteroids Tapering Delphi Expert Panel. Suehs CM, et al. Am J Respir Crit Care Med. 2021 Apr 1;203(7):871-881. doi: 10.1164/rccm.202007-2721OC. Am J Respir Crit Care Med. 2021. PMID: 33112646 Free article.
Current guidelines do not provide recommendations for OCS tapering in patients with asthma.Objectives: To develop expert consensus on OCS tapering among international experts.Methods: A modified Delphi method was used to develop expert consensus statements relating …
Current guidelines do not provide recommendations for OCS tapering in patients with asthma.Objectives: To develop expert consensus on …
6,894 results